The Live Nagpur
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary

The Live Nagpur

  • Home
  • City
  • Politics
  • Business
  • Education
  • Entertainment
  • Sports
  • Health
  • Crime
  • Forest
  • Featured
  • Vidarbha
Health & Wellness

US Pharma Firm Gilead Signs Pact with 3 Indian Drugmakers to Produce, Sell Remdesivir

by TLN Team May 14, 2020May 15, 2020
written by TLN Team May 14, 2020May 15, 2020
US Pharma Firm Gilead Signs Pact with 3 Indian Drugmakers to Produce, Sell Remdesivir

US drug-maker Gilead stated signing non-exclusive voluntary licensing agreements with Indian pharmaceutical companies including Cipla,Jubilant Life Sciences,andHetero Labs to expand the supply of Remdesivir the anti-viral drug to treat severe COVID-19 patients.

Gilead”s Remdesivir has received emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for the treatment of hospitalised patients with severe COVID-19 symptoms.

The agreements allow the companies – Cipla, Hetero Labs, Jubilant Lifesciences, Mylan and Pakistan-based Ferozsons Laboratories, to  manufacture remdesivir for distribution in 127 countries.

Gilead would provide technology transfers to the five drug manufacturers to facilitate the production.

Hetero which has been working with the ICMR for necessary approvals, said Remdesivir would be manufactured at its formulation facility in Hyderabad.

As part of the agreement, Cipla will be permitted to manufacture the active pharmaceutical ingredient (API) and finished product, and market it in 127 countries, including India and South Africa under Cipla”s own brand name.

Cipla will receive the manufacturing know-how from Gilead Sciences to manufacture the drug at a commercial scale.

In a statement, Jubilant whose subsidiary Jubilant Generics Ltd inked a pact with Gilead Sciences, said they are very happy to strengthen its partnership with the US giant to license remdesivir, “which, based on initial data, shows promise to be a potential therapy for COVID-19, a pandemic creating unprecedented health and economic crisis globally”.

The Health Ministry recently said that it is examining Remdesivir, which was used during the Ebola outbreak, as one protocol in the treatment for Covid-19 in the country.

0 comment
FacebookTwitterLinkedin
TLN Team

previous post
Severe impact of lockdown, video of man and ox pulling cart on highway goes viral
next post
Actress Huma Qureshi wants to “lunch” on cheeks of this actor

You may also like

Power outage at Daga Hospital for more than...

June 5, 2023

40 Medical Colleges lose recognition, 100 more under...

May 31, 2023

“I made a promise to my father…” Sachin...

May 31, 2023

NMC releases route map for bicycle rally on...

May 29, 2023

Son donates liver to save father’s life

May 27, 2023

Massive Turnout of 50,000 at ‘Yoga Mahotsav’ in...

May 27, 2023

AIIMS, Nagpur conducts an Awareness program on World...

May 25, 2023

Genomic Sequencing Laboratory at VRDL, AIIMS, Nagpur gets...

May 22, 2023

ENDOSCOPIC BRAIN SURGERY ON A 10 YEAR OLD...

May 18, 2023

Free yoga camp from May 13 

May 12, 2023

Trending News

  • Coromandel express accident: Train derailment in Odisha leaves over 200 dead, 900 injured

    June 3, 2023
  • Block spam calls using this step-by-step process

    June 2, 2023
  • Ahmednagar to be renamed Ahilyanagar

    May 31, 2023
  • Cricketer Deepak Chahar’s dance goes viral after CSK win

    May 30, 2023
  • Filmmaker Vignesh Shivan clicks selfies with Dhoni and Jadeja’s wives at IPL

    May 30, 2023

Important Links

  • Politics
  • Crime
  • Business
  • Education
  • Entertainment
  • Sports

Available on Playstore & Coming Soon on Appstore

Search

May 2020
M T W T F S S
« Apr   Jun »
 123
45678910
11121314151617
18192021222324
25262728293031

Sign-Up Form

Subscribe my Newsletter for new blog posts, tips & new photos. Let's stay updated!

Footer Logo
  • Nagpur City
  • Nagpur Education
  • Nagpur Sports
  • Business
  • Featured
  • Crime
  • Entertainment & Lifestyle
  • Health & Wellness
  • Nation
  • Politics
  • Trending
  • Vidarbha
  • Obituary
  • Privacy Policy
  • Cookie Policy
  • Terms Of Use
  • Advertise with Us

© 2020 - The Live Nagpur . All Rights Reserved.